• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Facial Filler Study Shows Less is More

New Orleans - Calcium hydroxylapatite is similar to other dermal fillers in terms of efficacy and ease of administration, but less of it is necessary to get the job done, according to a Stanford University-based retrospective, prospective study. The study was performed by Hayes B. Gladstone, M.D., director, dermatologic surgery, Stanford University, Palo Alto, Calif., in conjunction with Mountain View, Calif., private practice dermatologic surgeon Greg S. Morganroth, M.D.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.